208 related articles for article (PubMed ID: 16436742)
1. Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
Stucki A; Gerber P; Acosta F; Cottagnoud M; Cottagnoud P
Antimicrob Agents Chemother; 2006 Feb; 50(2):770-3. PubMed ID: 16436742
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus.
Reyes N; Skinner R; Benton BM; Krause KM; Shelton J; Obedencio GP; Hegde SS
J Antimicrob Chemother; 2006 Aug; 58(2):462-5. PubMed ID: 16735425
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Yin LY; Calhoun JH; Thomas TS; Wirtz ED
J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
[TBL] [Abstract][Full Text] [Related]
9. Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
Hegde SS; Skinner R; Lewis SR; Krause KM; Blais J; Benton BM
J Antimicrob Chemother; 2010 Apr; 65(4):725-8. PubMed ID: 20139142
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
[TBL] [Abstract][Full Text] [Related]
11. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model.
Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG
J Antimicrob Chemother; 2000 Dec; 46(6):981-5. PubMed ID: 11102418
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus.
Reyes N; Skinner R; Kaniga K; Krause KM; Shelton J; Obedencio GP; Gough A; Conner M; Hegde SS
Antimicrob Agents Chemother; 2005 Oct; 49(10):4344-6. PubMed ID: 16189117
[TBL] [Abstract][Full Text] [Related]
13. Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model.
Stucki A; Gerber P; Acosta F; Cottagnoud M; Cottagnoud P; Jiang L; Nguyen P; Wachtel D; Wang G; Phan LT
J Antimicrob Chemother; 2008 Mar; 61(3):665-9. PubMed ID: 18222952
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
15. A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.
Chan C; Hardin TC; Smart JI
Future Microbiol; 2015; 10(8):1325-38. PubMed ID: 26083676
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
[TBL] [Abstract][Full Text] [Related]
20. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
